Plasma galectin ‐3 levels do not differ in systemic lupus erythematosus patients

ConclusionsIn summary, plasma galectin ‐3 level was not significantly different between SLE patients and controls (P = .982). Further studies are needed to elucidate the role of galectin‐3 in SLE.

Source: International Journal of Rheumatic Diseases - August 10, 2019 Category: Rheumatology Authors: Chan ‐Na Zhao, Yan‐Mei Mao, Li‐Na Liu, Qian Wu, Yi‐Lin Dan, Hai‐Feng Pan Tags: ORIGINAL ARTICLE Source Type: research